* Information available to verified or subscribed users. The first stage in this process is to Register - please
click here to Register.
If you have already Registered, please click here to login.
|
| Phrase | Consultant | Town | Special Interests |
| clinical trial design and reporting | *Consultant(s)* | *Towns* | Interventional cardiology, stenting, angioplasty, clinical trial design and reporting, alcohol ablation in hypertrophic obstructive cardiomyopathy, transcatheter aortic valve implantation - TAVI |
| Currarino trial | *Consultant(s)* | *Towns* | Paediatric A&E, paediatric oncology, nutrition in surgical patients, foreskin development, foreskin problems, undescended testes, Currarino trial |
| fitness to plead/fitness to stand trial | *Consultant(s)* | *Towns* | Psychiatric reports for criminal cases in England and Wales, psychiatric defences including diminished responsibility, insanity, fitness to plead/fitness to stand trial, advice on hospital orders/other disposals, risk assessment and risk management, Parole Board reports, previously a member of the Board myself, GMC work - unable to provide independent reports for this, assessment of dangerousness |
| fitness to stand trial | *Consultant(s)* | *Towns* | General internal medicine, cardiology, heart failure, falls and syncope, stroke, pressure ulcers, rehabilitation, nursing home care, drug errors, fitness to stand trial, dementia and mental capacity assessment, clinical negligence |
| principal investigator for Opptimum trial | *Consultant(s)* | *Towns* | Minimal access surgery, colposcopy and cancer of the cervix, principal investigator for Opptimum trial, treatment of heavy periods and fibroids, total laparoscopic hysterectomy |
| principal investigator of STAR clinical trial | *Consultant(s)* | *Towns* | Medical retina - macular degeneration and diabetic retinopathy, principal investigator of STAR clinical trial |
| trial completed) | *Consultant(s)* | *Towns* | PI in MePFAC study: Methylphenidate v Placebo in management of fatigue in advanced cancer (RCT, double-blinded, trial completed), Sub PI in Chelsea II Study (Hydration at the end of life) |
|
|
|
|
